Clinical Trials
25 trialsSevAsthma
Assistance Publique - HĂ´pitaux de Paris
Asthma In-Home Monitoring (AIM) Trial
Tripler Army Medical Center
gp-multitool
Universitätsklinikum Hamburg-Eppendorf
EPLLMMRDC
North Sichuan Medical College
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
SWIFT
University of Southern California
CREST
MetroHealth Medical Center
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PrIGMa
Imperial College London
PACEinMM-QC
Université de Sherbrooke
FAst
The Cleveland Clinic
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
Boston University
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
WIN
University of Florida
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
National Institutes of Health Clinical Center (CC)
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
Gemini Symbicort pMDI
AstraZeneca
Study Evaluating Etanercept in Moderate to Severe Asthma
Wyeth is now a wholly owned subsidiary of Pfizer
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Hospital General de Requena
TNF Alpha in Refractory Asthma
University Hospitals, Leicester